Why Novocure Stock Fell More Than 10% in March
Novocure (NASDAQ: NVCR) stock dropped 10.3% in March, according to data from S&P Global Market Intelligence. For context, the S&P 500 returned 1.9% last month.
Despite this decline, shares of the maker of a device for treating brain cancer with electric fields have gained 38.3% in 2019, and are up a whopping 126% over the last year through April 5.
Image source: Novocure.
Source Fool.com
